SMARCB1 loss was detected in most of these cases (9/11), including eight SCCs and one mixed neuroendocrine/non-neuroendocrine neoplasm (MiNEN), composed of a LCNEC and a NKSCC. The gene discussed is SMARCB1; the disease is neuroendocrine neoplasm.